In this study, a 4-methylation marker panel was identified and validated, while the HelioLiver test identified a 28-methylation marker panel targeting 77 CpG sites and the multitarget HCC blood40 includes two methylation markers (HOXA1 and TSPYL5). Here, TSPYL5 is linked to hepatocellular carcinoma.